Articles in section Mergers & Acquisitions
<< Licensing | 662 articles | Opinion & Analysis >> |
<< Previous | Pages 1 2 3 4 5 .. 67 | Next >> |
-
AbbVie to Buy Cerevel Therapeutics for US$8.7 B to Bolster Neuroscience Portfolio
-
AbbVie to Acquire ImmunoGen for US$10.1 B
-
Merck & Co. to Acquire Caraway Therapeutics for Up to US$610 M
-
Basilea Pays US$37 M Upfront for Antifungal from Pfizer’s Amplyx
-
Roche Pays US$7.1 B for Bowel Disease Drug from Roivant and Pfizer
-
Novo Nordisk to Acquire Ocedurenone for Hypertension from KBP Biosciences
-
Alfasigma to Acquire Intercept Pharmaceuticals to Expand into Liver Diseases
-
Kyowa Kirin to Acquire Orchard Therapeutics for US$477.6 M
-
Eli Lilly to Acquire Point Biopharma to Strengthen its Oncology Portfolio
-
Bristol Myers Squibb to Acquire Mirati Therapeutics for Up to US$5.8 B